Dr. Cantley was inducted into the OncLive 2017 Giants of Cancer Care recognition program.
A $12 million award from the Stand Up to Cancer Foundation will help fund trials testing Vitamin C as a therapy for patients with colon, lung and pancreatic cancers.
Diabetes drug phenformin shows promise as a treatment for melanoma, according to research from Lewis Cantley, Ph.D., and Jonathan Zippin, M.D., Ph.D.
Dr. Cantley was recently elected as Chairman of the Board of Trustees of the Hope Funds for Cancer Research, a charity dedicated to advancing innovative research for the most difficult-to-treat cancers.
Dr. Cantley will receive $4.2 million over 7 years to continue his research into PI3K and cancer metabolism.
Lewis C. Cantley, Ph.D., and Kristy Richards, Ph.D., M.D. are collaborating to revamp the ways cancer drugs can be researched, tested and approved.
Dr. Cantley was among seven selected for the third round of the Daedalus Fund for Innovation awards.
The metabolic state of patients influences their cancer risk, progression and response to treatment.
A new study echoes the findings of the Cantley Lab regarding the potential of Vitamin C as a cancer-killing therapy.
Cornell University and Weill Cornell will establish a new multi-institutional translational research Center on the Physics of Cancer Metabolism, thanks to a $9.3m National Cancer Institute grant
Weill Cornell Medicine
Weill Cornell Medical College
Meyer Cancer CenterBelfer Research Building413 E 69th St.Room 1362, Box 50
New York, NY 10021
Phone: (646) 962-6297